The Preparative and Process Chromatography market is expected to grow at a CAGR of 11.65% to reach USD 17.26 billion in 2028.
.jpg "The Global Preparative And Process Chromatography Market 2018-2028 (USD Billion)")
The global preparative and process chromatography market was valued at USD 6.76 billion in 2020 and is projected to grow at a CAGR of 6.2% during the forecast period. Factors driving the growth of the preparative and process chromatography market include growing demand for biopharmaceutical products, technology invention and presence of contemporary technologies for chromatographic instruments.
The global preparative and process chromatography market is segmented based on type and end use. On the basis of type, the market is segmented into preparative and process chromatography. The process chromatography was the largest market in 2019. By end use, the market is segmented into food and nutraceutical industry, biotechnology and pharmaceutical industry, and academic research laboratories. The biotechnology and pharmaceutical industry segment accounted for the largest share of the global preparative and process chromatography market and is projected to sustain its dominance over the forecast period.
Regionally, North America accounted for the largest market share of the global preparative and process chromatography market attributable to increasing healthcare set-up. Leading players of the global preparative and process chromatography market include GE Healthcare, Merck KGaA, Pall Corporation, Bio-Rad Laboratories, Shimadzu Corporation, Chiral Technologies, Inc., Thermo Fisher Scientific Inc., Waters Corporation, Agilent Technologies, Novasep Holding S.A.S among others.
Preparative and Process Chromatography Market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2028 |
| Study Period | 2018-2028 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2028 | USD 17.26 billion |
| Growth Rate | CAGR of 11.65% during 2018-2028 |
| Segment Covered | By Product, Regions |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Key Players Profiled | GE Healthcare, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific Inc., Shimadzu Corporation, Novasep Holding S.A.S, Waters Corporation |
Key Segment Of The Preparative and Process Chromatography Market
Preparative And Process Chromatography Product
o Process Chromatography
• System
• Multi-use Batch Chromatography Systems
• Single-use Batch Chromatography Systems
• Continuous Chromatography Systems
• Consumables
• Reagents
• Resins
• Affinity Resins
• Ion-exchange Resins
• Size-exclusion Resins
• Hydrophobic Interaction Resins
• Reversed Phase Resins
• Mixed-mode/Multi-mode Resins
• Columns
• Prepacked Columns
• Automated Columns
• Manual Columns
• Services
o Preparative Chromatography
• System
• Semi-preparative Chromatography Systems
• Other Chromatography Systems
• Consumables
• Reagents
• Resins
• Affinity Resins
• Ion-exchange Resins
• Size-exclusion Resins
• Hydrophobic Interaction Resins
• Reversed Phase Resins
• Mixed-mode/Multi-mode Resins
• Columns
• Prepacked Columns
• Empty Columns
• Services
Preparative And Process Chromatography Type
• HPLC
• Flash/Column Chromatography
• Ion-exchange chromatography
• Size-exclusion chromatography
• Affinity chromatography
o Gas Chromatography
o Thin Layer Chromatography
o Paper Chromatography
o Gel-permeation (Molecular Sieve) Chromatography
o Hydrophobic Interaction Chromatography
Preparative And Process Chromatography End-use
• Pharmaceutical
• Biotechnology
• Food
• Nutraceutical
• Others
Regional Overview
North America
• US
• Canada
Europe
• Germany
• France
• UK
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
South America
• Mexico
• Brazil
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
the preparative and process chromatography market is growing at a CAGR of 11.65 % during the forecast period.
The base year for the report is 2022 in preparative and process chromatography market
North America dominated the market for preparative and process chromatography market and accounted for the largest revenue share.
Biopharmaceutical producers initially focused on the quest for better production titers. As a result, the productivity bottleneck shifted from upstream to downstream processing. With the support of the US Food and Drug Administration (FDA) and other regulatory bodies, industrial players are now looking for more integrated approaches to develop high-performance processes in a competitive and pressurized environment. A particular driver for more cost-effective processes is biosimilar and bio better production. Chromatography remains the workhorse of modern biologics purification processes, with typically at least two orthogonal chromatography steps allowing purity (of greater than 99 per cent) to be reached. Depending on the product (small molecules or large biologics) and process characteristics, the technology can be operated under low or high pressure with chiral, reverse-phase, affinity or ion exchange media.
The preparative chromatography is expected to grow at a highest CAGR by 2028. Preparative chromatography is a novel technique that can be applied as a pre-cursor to efficiently determine the structures of the unknown impurities or purify a sample to meet specification. Dealing with these unknown impurities, for example in finished products, stability samples or discovery compounds, can be very challenging as failure to identify or remove them might interrupt product supply, delay clinical studies or interfere with toxicology studies. Very often there is a regulatory requirement to disclose structure of new impurities above a certain limit. The financial loss to the pharmaceutical, agrochemical, food and consumer goods and fine chemical industry can be enormous.
North America dominated the market for preparative and process chromatography in 2019. Among U.S. industries, the biopharmaceutical industry stands out as a leader in innovation-led development. The comparative data can be striking. For example, the Brookings Institution in its report on advanced industries found that the biopharmaceutical industry has the highest R&D spending per worker far exceeding the next highest industry, communications equipment, by more than 57%. The biopharmaceutical industry invests more than USD114,000 per employee in R&D, the largest among key U.S. industrial sectors. This figure is more than six times larger than the R&D per employee average for all U.S. industries and more than four times larger than the manufacturing sector as a whole. All these factors are expected to propel the preparative and process chromatography market in this region.